Randomized, phase III, double-blind, vehicle-controlled clinical trial to evaluate the safety and efficacy of 12 weeks of twice-daily azelaic acid foam, 15% in papulopustular rosacea

被引:0
作者
Draelos, Zoe D. [1 ]
Elewski, Boni E. [2 ]
Harper, Julie C. [3 ]
Sand, Meike [4 ]
Staedtler, Gerald [4 ]
Nkulikiyinka, Richard [4 ]
Shakery, Kaweh [4 ]
机构
[1] Dermatol Consulting Serv, High Point, NC USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Dermatol & Skin Care Ctr Birmingham PC, Birmingham, AL USA
[4] Bayer Healthcare, Global Dev, Berlin, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
850
引用
收藏
页码:AB59 / AB59
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee - A randomized, double-blind, vehicle-controlled clinical trial
    Roth, SH
    Shainhouse, JZ
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) : 2017 - 2023
  • [22] Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea
    Brenenman, D
    Savin, R
    VandePol, C
    Vamvakias, G
    Levy, S
    Leyden, J
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (05) : 381 - 387
  • [23] A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea
    Ulrich Mrowietz
    Tal Hetzroni Kedem
    Rita Keynan
    Meir Eini
    Dov Tamarkin
    Dror Rom
    Mitchell Shirvan
    American Journal of Clinical Dermatology, 2018, 19 : 427 - 436
  • [24] A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea
    Mrowietz, Ulrich
    Kedem, Tal Hetzroni
    Keynan, Rita
    Eini, Meir
    Tamarkin, Dov
    Rom, Dror
    Shirvan, Mitchell
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (03) : 427 - 436
  • [25] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
    Stockfleth, Eggert
    von Kiedrowski, Ralph
    Dominicus, Rolf
    Ryan, John
    Ellery, Adam
    Falques, Meritxell
    Ivanoff, Nathalie
    Rodriguez Azeredo, Rosario
    DERMATOLOGY AND THERAPY, 2017, 7 (01) : 81 - 96
  • [26] Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
    Weinstein, GD
    Koo, JYM
    Krueger, GG
    Lebwohl, MG
    Lowe, NJ
    Menter, MA
    Lew-Kaya, DA
    Sefton, J
    Gibson, JR
    Walker, PS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (05) : 760 - 767
  • [27] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
    Eggert Stockfleth
    Ralph von Kiedrowski
    Rolf Dominicus
    John Ryan
    Adam Ellery
    Meritxell Falqués
    Nathalie Ivanoff
    Rosario Rodriguez Azeredo
    Dermatology and Therapy, 2017, 7 : 81 - 96
  • [28] Twice Daily Versus Once Nightly Dosing of Pregabalin for Fibromyalgia: A Double-Blind Randomized Clinical Trial of Efficacy and Safety
    Nasser, Keaton
    Kivitz, Alan J.
    Maricic, Michael J.
    Silver, David S.
    Silverman, Stuart L.
    ARTHRITIS CARE & RESEARCH, 2014, 66 (02) : 293 - 300
  • [29] Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial
    Yang, Chao-Chun
    Wong, Tak-Wah
    Lee, Chih-Hung
    Hong, Chien-Hui
    Chang, Chung-Hsing
    Lai, Feng-Jie
    Lin, Shang-Hung
    Chi, Ching-Chi
    Lin, Tzu-Kai
    Yen, Hsi
    Wu, Chin-Han
    Sheu, Hamm-Ming
    Lan, Cheng-Che E.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (03) : 295 - 302
  • [30] Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
    Szeimies, RM
    Gerritsen, MJR
    Gupta, G
    Ortonne, JP
    Serresi, S
    Bichel, J
    Lee, JH
    Fox, TL
    Alomar, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) : 547 - 555